Hsiaoyin Mao

4.6k citations
32 papers · 3.4k indexed · 1 hit paper · h-index 25

Hsiaoyin Mao

32 papers receiving 3.3k citations

Hit Papers

Essential metabolic, anti-inflammatory, and anti-tumorige...6232012202620162021200400600

Peers

Hsiaoyin Mao
Comparison fields: 5 of 98
  • Immunology 1.9k
  • Cancer Research 625
  • Hematology 384
  • Oncology 716
  • Hepatology 129
Replace Ines Gütgemann with:
Ines Gütgemann Germany
Kevin P. Baker United States
Olle Sangfelt Sweden
Maria Antonia Frassanito Italy
Elizabeth Raveché United States
Frank Grünebach Germany
Doriana Fruci Italy
Katia Beider Israel
Evan Lind United States
Tomoharu Yasuda Japan
Hsiaoyin Mao relative to Ines Gütgemann Germany Ines Gütgemann's profile →
Citations per field
00.5×1.5×2.1×
Ines Gütgemann · 1×
Citations per year

Countries citing papers authored by Hsiaoyin Mao

Since Specialization
Citations

This map shows the geographic impact of Hsiaoyin Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsiaoyin Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsiaoyin Mao more than expected).

Fields of papers citing papers by Hsiaoyin Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsiaoyin Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsiaoyin Mao. The network helps show where Hsiaoyin Mao may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hsiaoyin Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hsiaoyin Mao Line = papers co-authored together Hsiaoyin Mao links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201927
2 201728
3 2016142
4 2015129
5 201443
6 201438
7 201368
8
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liverbreakdown →
2012623
9 2012167
10 201158
11 201051
12 2009184
13 200925
14 200915
15 2008207
16 200743
17 2006223
18 2006322
19 2005370
20 2005284

About Hsiaoyin Mao

Hsiaoyin Mao is a scholar working on Immunology, Cancer Research and Oncology, having authored 32 papers that have together received 3.4k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (24 papers), T-cell and B-cell Immunology (15 papers), CAR-T cell therapy research (7 papers), IL-33, ST2, and ILC Pathways (4 papers), Epigenetics and DNA Methylation (3 papers), MicroRNA in disease regulation (3 papers), Immunotherapy and Immune Responses (3 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Immunology (1.9k citations), Cancer Research (625 citations) and Hematology (384 citations). Hsiaoyin Mao has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Michael A. Caligiuri, Jianhua Yu, Aharon G. Freud, Brian Becknell, Rossana Trotta, Wei Min, Tiffany Hughes, Amy K. Ferketich, Akihiko Yokohama and Guido Marcucci. Their work appears in journals such as Journal of Clinical Investigation, Nature Medicine and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026